Israeli Pharmaceutical Company to Offer Generic Viagra Pill, Cost to be Reduced by 90%
×
[contact-form-7 404 "Not Found"]
by Zach Pontz
Viagra. Photo: Wikipedia.
Israel-based Teva Pharmaceutical Industries Ltd. is set to launch a generic form of the impotence-alleviating pill Viagra in Europe, Globes reported Friday.
The patent held by Pfizer Inc., which is located in the United States, expires in the UK and other countries this weekend, allowing Teva to launch the generic version. Teva will call their version Sildenafil. The cost of the pill will be reduced considerably, from £10 to £1 in the UK for instance.
However, Teva will be unable to provide Sildenafil to the U.S. market after a court ruled that the patent there is valid until 2020.
Share this Story:
Let your voice be heard!
Join the Algemeiner
Trending
-
Iranian, 2 Others Detained in Peru Over Plot to Kill Israelis
-
US, 17 Other Countries Urge Hamas to Release Hostages, End Gaza Crisis
-
It’s All About ‘Time’: Israel Cannot Survive If It Does Not Address Iranian Nuclear Weapons
-
WIll Israel-Iran Conflict Spiral Out of Control — or Will Both Sides Play It Safe?
-
US Academic Skews Stats to Compare Gaza to Actual Case of Genocide